GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Other Operating Expense

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Other Operating Expense : ¥145 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Other Operating Expense?

Sichuan Goldstone Asia Pharmaceutical's Other Operating Expense for the three months ended in Mar. 2024 was ¥3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥145 Mil.

Sichuan Goldstone Asia Pharmaceutical's quarterly Other Operating Expense increased from Sep. 2023 (¥-53 Mil) to Dec. 2023 (¥138 Mil) but then declined from Dec. 2023 (¥138 Mil) to Mar. 2024 (¥3 Mil).

Sichuan Goldstone Asia Pharmaceutical's annual Other Operating Expense declined from Dec. 2021 (¥129 Mil) to Dec. 2022 (¥126 Mil) but then increased from Dec. 2022 (¥126 Mil) to Dec. 2023 (¥142 Mil).


Sichuan Goldstone Asia Pharmaceutical Other Operating Expense Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Other Operating Expense Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 135.51 124.99 129.17 125.63 142.38

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 57.01 -53.38 137.97 3.04

Sichuan Goldstone Asia Pharmaceutical Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Goldstone Asia Pharmaceutical Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sichuan Goldstone Asia Pharmaceutical's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Traded in Other Exchanges
N/A
Address
8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines